
Specialist IP cover for patents, trademarks, copyright and trade secrets. We arrange insurance that can cover defending infringement claims and pursuing infringers, subject to policy terms.
SaaS and product businesses exposed to patent assertions and open‑source licence disputes.
Companies whose products, designs and processes can attract patent or design‑right claims.
Businesses that rely on trademarks and trade dress, and face counterfeiting or passing‑off.
Agencies, publishers and studios whose work is protected by copyright and moral rights.
R&D‑led companies with granted or pending patents and valuable trade secrets.
Businesses that give IP indemnities to customers, partners or investors under contract.
Defending allegations that you infringe someone else's patent, and enforcing your own granted patents against infringers. Pending applications may be considered, subject to insurer confirmation.
A single section for trademarks, copyright, trade secrets and design rights – the full portfolio beyond patents.
Our current IP solution offers pursuit cover only alongside a defence policy, with a maximum pursuit limit of £1m in the first year. Defence is available up to £5m, subject to underwriting.
Examples of exposures – cover depends on the policy wording and is not a guarantee of any claim outcome.
A software business is told its product infringes a competitor's patent.
A customer contract requires you to give an IP indemnity.
A competitor appears to have copied your protected work.
A former employee is accused of bringing confidential information to a rival.
No lengthy questionnaire. Your contact details, the business, your website and gross revenue – that's all we need to start. Initial response within one business day.
GMG Insurance places intellectual property risk with specialist markets, working with underwriters who price patents, trademarks and trade secrets every day.

The English High Court has refused Thomas Pink’s application to stop Victoria’s Secret pursuing US trademark infringement proceedings. It held that the disputed products fell outside the protection of the businesses’ worldwide coexistence agreement.
The High Court refused Thomas Pink’s application to stop Victoria’s Secret pursuing a US infringement claim over externally branded PINK womenswear. The court found that internal THOMAS PINK labels did not bring the external branding within the protection claimed under the parties’ 2015 settlement.
The English High Court granted a novel form of declaratory relief in Fujifilm Kyowa Kirin Biologics v AbbVie Biotechnology [2017] EWHC 395 (Pat). The source describes the ruling as a way to help clear a product’s route to market where pending patent applications cannot be challenged in court.